Leslie Mertz (email@example.com) is a freelance science, medical, and technical writer, author, and educator living in northern Michigan.
Until a dangerous bacterial infection left her husband near death 3 years ago, scientist Steffanie Strathdee had never heard of bacteriophage therapy. After it ultimately saved his life, however, she not only has become a staunch advocate of the therapy, but also now serves as co-director of the newly established Center for Innovative Phage Applications and Therapeutics at the University of California San Diego.
Only a few years ago, leading autism expert David Amaral described the disorder as a lifelong disability. Today, he acknowledges that description is no longer true. “Research lately shows that a substantial proportion of children with autism spectrum disorder (ASD) show really substantial improvements in their autism symptoms,” says Amaral.
When an artery is blocked, stents are often the best way to open up the vessel. A mesh stent is tightly crimped over a tiny balloon and guided to the troubled spot; the balloon is inflated, expanding the stent, which forces the vessel open. Blood flow is restored.
Innovative researchers are employing flexible, rather than rigid materials in combination with new design approaches as part of the emerging field of biomedical soft robotics. The idea is to generate tools that conform to and interact with the human body in a much more natural and lightweight way, providing better treatment options for clinicians and translating into better outcomes for patients.
Work is already underway to bring blockchain technology to the healthcare industry, and hospital administrators are trying to figure out what it can do for them, their clinicians, and their patients. That includes administrators at Beth Israel Deaconess Medical Center, a leading academic medical center located in Boston. We interviewed the medical center’s chief information officer (CIO), John D. Halamka, M.D.
A blockchain revolution sweeps into health care, offering the possibility for a much-needed data solution.
Nuclear medicine has come a long way in a short time. Over the past three decades alone, it has taken two major steps forward and is now on the precipice of yet another advance that could begin to have a real impact on cancer care within the year.
Gene editing and CRISPR typically target disease-causing mutated genes by eliminating the bad gene altogether.
Of the key technologies listed as “ready to propel industries and transform our world” in the 2017 report Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative, most fall under the scope of BME. Issued by the major market research and analysis company Frost and Sullivan, the report’s findings are no surprise to those who are heavily invested in this field.
Micro- and nanorobots prepare to advance medicine.